Oncology and Hematology
Episodes 33-48 of 296
- Project Oncology®
Myeloma Matters: Bispecific Antibody Horizons: Dosing Strategies and Meeting Updates in Myeloma Care
Saad Z. Usmani, MD, MBA, FACP
Joshua Richter, MD
Ashley Steinberger, APP
Charles Turck, PharmD, BCPS, BCCCP
Christopher Chambers, MD
Adam H. Buchanan, MS, MPH
- Project Oncology®
Uncovering New Biomarkers for RCC: A Review of Emerging Techniques
Jody Takemoto, PhD
David Braun
- Project Oncology®
Precision Strikes in Nuclear Medicine to Treat Prostate Cancer
Munir Ghesani, MD
- Project Oncology®
Enhancing HCC Outcomes Through Multidisciplinary Care
Charles Turck, PharmD, BCPS, BCCCP
Hannah Lee, MD
- Project Oncology®
The Potential Impact of RCC Molecular Subtypes on Treatment Outcomes
Jody Takemoto, PhD
David Braun, MD, PhD
- Project Oncology®
Optimizing HCC Screening: Strategies to Overcome Common Barriers
Hannah Lee, MD
Jennifer Caudle, DO
Patricia A. Mangan, RN, MSN, APRN-BC
Jody Takemoto, PhD
Robert Wong, MD
- Project Oncology®
An Overview of the Fundamentals of PET-CT Imaging
- Project Oncology®
Key Highlights from SNMMI 2024
- Project Oncology®
An Exploration of Multiple Myeloma Treatments
- Project Oncology®
Myeloma Matters: Prevention and Management of Bispecific Antibody–Associated Adverse Events in Multiple Myeloma
Jesus G. Berdeja, MD
Nicholas G. Barkemeyer, MPAS
Ajai Chari, MD
Harvey Church
Amy Gebhardt
Steven Morrow
Matt Birnholz, MD
Saad Kenderian M.B, Ch.B
- Project Oncology®
MCED Testing: Confirming a Positive Result with Diagnostic Follow-Up
Brian P. McDonough, MD, FAAFP
Betsy O'Donnell, MD
Tomasz Beer, MD, FACP
Jody Takemoto, PhD
Robert Wong, MD